HKD40.70
2.05% today
Hong Kong, Jun 13, 10:08 am CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Stock price

HKD41.55
+3.60 9.49% 1M
+11.00 36.01% 6M
+13.45 47.86% YTD
+17.10 69.94% 1Y
-68.45 62.23% 5Y
-68.45 62.23% 10Y
-68.45 62.23% 20Y
Hong Kong, Closing price Thu, Jun 12 2025
+0.90 2.21%
ISIN
KYG5074A1004
Symbol
6618
Index
Sector

Key metrics

Market capitalization HKD130.08b
Enterprise Value HKD74.31b
P/E (TTM) P/E ratio 28.85
EV/FCF (TTM) EV/FCF 15.84
EV/Sales (TTM) EV/Sales 1.17
P/S ratio (TTM) P/S ratio 2.04
P/B ratio (TTM) P/B ratio 2.20
Revenue growth (TTM) Revenue growth 8.65%
Revenue (TTM) Revenue HKD63.64b
EBIT (operating result TTM) EBIT HKD3.55b
Free Cash Flow (TTM) Free Cash Flow HKD4.69b
Cash position HKD56.06b
EPS (TTM) EPS HKD1.44
P/E forward 34.05
P/S forward 1.79
EV/Sales forward 1.02
Show more

Is JD Health International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

JD Health International Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a JD Health International forecast:

16x Buy
73%
5x Hold
23%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a JD Health International forecast:

Buy
73%
Hold
23%
Sell
5%

Financial data from JD Health International

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
63,638 63,638
9% 9%
100%
- Direct Costs 49,076 49,076
8% 8%
77%
14,562 14,562
12% 12%
23%
- Selling and Administrative Expenses 11,488 11,488
6% 6%
18%
- Research and Development Expense 1,456 1,456
8% 8%
2%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 3,551 3,551
263% 263%
6%
Net Profit 4,554 4,554
94% 94%
7%

In millions HKD.

Don't miss a Thing! We will send you all news about JD Health International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. Its technology-driven platform is cantered on the supply chain of pharmaceutical and healthcare products and healthcare services, encompassing a user’s full life span for all healthcare needs. The firm's retail pharmacy business operates through three models: direct sales, online marketplace and Omni channel initiative. It offers comprehensive online healthcare services, such as online consultation and prescription renewal, chronic disease management, family doctor and consumer healthcare. Its platform allows doctors to practice multisite, acquire and manage targeted patients, conduct healthcare research, exchange academic and clinical knowledge and improve diagnostic and treatment skills. The company was founded on November 30, 2018 and is headquartered in Beijing, China.

Head office Cayman Islands
CEO En Jin
Employees 3,177
Founded 2018
Website ir.jdhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today